BACKGROUND: The aetiology of age-related macular degeneration (AMD) and cognitive impairment is poorly understood. A link between cognitive impairment and AMD has been proposed although only a weak association was found in population-based studies. PURPOSE: To assess cross-sectional associations between AMD and cognitive impairment in an older Australian population. METHODS: The Blue Mountains Eye Study examined 3,509 persons aged 49+ years during 1997-2000. AMD lesions were assessed from retinal photographs using the Wisconsin System. Mini-mental state examination (MMSE), demographics, lifestyle factors and medical history were collected at interview. MMSE score was categorised as high-normal (28-30), low-normal (24-27) and impaired (< 24). A modified MMSE excluded five vision related items and was dichotomised as normal (18-22) and impaired (0-17). Logistic regression was used to assess associations after adjusting for age, sex, visual impairment, stroke, current smoking status, hypertension, alcohol consumption and post-high-school qualification. RESULTS: Prevalence rates for late and early AMD were 1.5% (n = 50) and 8.3% (n = 273), respectively. Cognitive impairment was present in 18.0% in persons with late AMD and 8.4% with early AMD, compared to 2.6% in persons without AMD. After multivariate adjustment, late AMD was associated with low normal MMSE (odds ratio (OR): 2.2, 95% confidence interval (CI): 1.1-5.0) and cognitive impairment (OR: 3.7, CI: 1.3-10.6). Using the modified MMSE, the multivariate association between late AMD and cognitive impairment remained (OR: 2.2, CI: 1.0-5.0). No significant association was found between cognitive impairment and early AMD. CONCLUSIONS: We found a significant, cross-sectional association between late AMD and cognitive impairment in a sample of older Australians that appeared to be independent of visual impairment. The association was weaker but remained significant after excluding vision-related items from the MMSE. Copyright (c) 2006 S. Karger AG, Basel.
BACKGROUND: The aetiology of age-related macular degeneration (AMD) and cognitive impairment is poorly understood. A link between cognitive impairment and AMD has been proposed although only a weak association was found in population-based studies. PURPOSE: To assess cross-sectional associations between AMD and cognitive impairment in an older Australian population. METHODS: The Blue Mountains Eye Study examined 3,509 persons aged 49+ years during 1997-2000. AMD lesions were assessed from retinal photographs using the Wisconsin System. Mini-mental state examination (MMSE), demographics, lifestyle factors and medical history were collected at interview. MMSE score was categorised as high-normal (28-30), low-normal (24-27) and impaired (< 24). A modified MMSE excluded five vision related items and was dichotomised as normal (18-22) and impaired (0-17). Logistic regression was used to assess associations after adjusting for age, sex, visual impairment, stroke, current smoking status, hypertension, alcohol consumption and post-high-school qualification. RESULTS: Prevalence rates for late and early AMD were 1.5% (n = 50) and 8.3% (n = 273), respectively. Cognitive impairment was present in 18.0% in persons with late AMD and 8.4% with early AMD, compared to 2.6% in persons without AMD. After multivariate adjustment, late AMD was associated with low normal MMSE (odds ratio (OR): 2.2, 95% confidence interval (CI): 1.1-5.0) and cognitive impairment (OR: 3.7, CI: 1.3-10.6). Using the modified MMSE, the multivariate association between late AMD and cognitive impairment remained (OR: 2.2, CI: 1.0-5.0). No significant association was found between cognitive impairment and early AMD. CONCLUSIONS: We found a significant, cross-sectional association between late AMD and cognitive impairment in a sample of older Australians that appeared to be independent of visual impairment. The association was weaker but remained significant after excluding vision-related items from the MMSE. Copyright (c) 2006 S. Karger AG, Basel.
Authors: Mark W Albers; Grover C Gilmore; Jeffrey Kaye; Claire Murphy; Arthur Wingfield; David A Bennett; Adam L Boxer; Aron S Buchman; Karen J Cruickshanks; Davangere P Devanand; Charles J Duffy; Christine M Gall; George A Gates; Ann-Charlotte Granholm; Takao Hensch; Roee Holtzer; Bradley T Hyman; Frank R Lin; Ann C McKee; John C Morris; Ronald C Petersen; Lisa C Silbert; Robert G Struble; John Q Trojanowski; Joe Verghese; Donald A Wilson; Shunbin Xu; Li I Zhang Journal: Alzheimers Dement Date: 2014-07-09 Impact factor: 21.566
Authors: Heather E Whitson; Ying-Hui Chou; Guy G Potter; Michele T Diaz; Nan-Kuei Chen; Eleonora M Lad; Micah A Johnson; Scott W Cousins; Jie Zhuang; David J Madden Journal: Brain Connect Date: 2014-12-02
Authors: S Gillette Guyonnet; G Abellan Van Kan; S Andrieu; J P Aquino; C Arbus; J P Becq; C Berr; S Bismuth; B Chamontin; T Dantoine; J F Dartigues; B Dubois; B Fraysse; T Hergueta; H Hanaire; C Jeandel; S Lagleyre; F Lala; F Nourhashemi; P J Ousset; F Portet; P Ritz; P Robert; Y Rolland; C Sanz; M Soto; J Touchon; B Vellas Journal: J Nutr Health Aging Date: 2008-10 Impact factor: 4.075
Authors: Heather E Whitson; Diane Whitaker; Guy Potter; Eleanor McConnell; Fay Tripp; Linda L Sanders; Kelly W Muir; Harvey J Cohen; Scott W Cousins Journal: JAMA Ophthalmol Date: 2013-07 Impact factor: 7.389
Authors: M Secher; M Soto; S Gillette; S Andrieu; H Villars; B Vellas; C Tabone; J-B Chareyras; O Dubois; C-F Roques; B Dubois Journal: J Nutr Health Aging Date: 2009-11 Impact factor: 4.075
Authors: Michelle L Baker; Jie Jin Wang; Sophie Rogers; Ronald Klein; Lewis H Kuller; Emily K Larsen; Tien Yin Wong Journal: Arch Ophthalmol Date: 2009-05